Donald Trump, AP (Photo by: Dennis Van Tine/STAR MAX/IPx 2020)
October 9, 2020 07:11 AM EDTUpdated 08:02 AM
Pharma

As Trump touts his ‘great’ Covid drugs, the phar­ma cash flows to Biden, not him

Kaiser Health News

Phar­ma­ceu­ti­cal gi­ants Re­gen­eron and Gilead Sci­ences got the kind of pub­lic­i­ty mon­ey can’t buy this week af­ter Pres­i­dent Don­ald Trump took their ex­per­i­men­tal drugs for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times